BRIDGETTE COATS: Open Payments
NPI 1508370255 · LAKEWOOD, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$399 in 17 payments from 11 companies in 2025. Trend: 2023 $631 · 2024 $318 · 2025 $399
Food & beverage: $399
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $104 |
| Stemline Therapeutics Inc. | 2 | $42 |
| Iovance Biotherapeutics, Inc. | 2 | $41 |
| PFIZER INC. | 2 | $40 |
| Gilead Sciences, Inc. | 1 | $31 |
| Astellas Pharma US Inc | 1 | $30 |
| Ipsen Biopharmaceuticals, Inc | 1 | $25 |
| AstraZeneca Pharmaceuticals LP | 1 | $24 |
| Syndax Pharmaceuticals, Inc. | 1 | $22 |
| SANOFI-AVENTIS U.S. LLC | 1 | $20 |
Products named: EPKINLY, ELZONRIS, Amtagvi, ELREXFIO, Trodelvy, Vyloy, Tazverik, IMFINZI.
Industry payments across CO — which companies pay providers there.
